{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:46:26Z","timestamp":1779252386926,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFD235"],"award-info":[{"award-number":["2024AFD235"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20297"],"award-info":[{"award-number":["U21A20297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.mtbio.2025.101581","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:32:47Z","timestamp":1740627167000},"page":"101581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Construction of dual-targeted liposomes loaded with celastrol and their application in treating intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Jun","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2095-494X","authenticated-orcid":false,"given":"Cong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mtbio.2025.101581_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101581_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101581_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14737140.2022.1999809","article-title":"Surgical management of intrahepatic cholangiocarcinoma","volume":"22","author":"Hewitt","year":"2021","journal-title":"Expet Rev. Anticancer Ther."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101581_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.30289","article-title":"Intrahepatic cholangiocarcinoma: continuing challenges and translational advances","volume":"69","author":"Sirica","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101581_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/s41401-020-00572-6","article-title":"Celastrol induces lipophagy via the LXR\u03b1\/ABCA1 pathway in clear cell renal cell carcinoma","volume":"42","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"18","key":"10.1016\/j.mtbio.2025.101581_bib7","first-page":"2147","article-title":"Effects of celastrol on apoptosis of intrahepatic cholangiocarcinoma cells","volume":"38","author":"Rao","year":"2022","journal-title":"Clinical and Basic Bridging Research"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101581_bib8","article-title":"VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference","volume":"27","author":"Nibali","year":"2024","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101581_bib9","article-title":"Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma","volume":"18","author":"Luo","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101581_bib10","article-title":"Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis","volume":"4","author":"Blagosklonny","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101581_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-022-03741-9","article-title":"Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101581_bib12","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jcp.25349","article-title":"Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy","volume":"231","author":"Yang","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s13346-023-01421-9","article-title":"Ultrasound-mediated multifunctional magnetic microbubbles for drug delivery of celastrol in VX2 liver transplant tumors","author":"Huang","year":"2024","journal-title":"Drug delivery translational research"},{"key":"10.1016\/j.mtbio.2025.101581_bib14","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.2147\/IJN.S165590","article-title":"Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.101581_bib15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2147\/IJN.S449042","article-title":"Combined photosensitive gene therapy effective against triple-negative breast cancer in mice model","author":"Hu","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.mtbio.2025.101581_bib16","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.7150\/thno.35748","article-title":"Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy","volume":"9","author":"Yu","year":"2019","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.mtbio.2025.101581_bib17","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1021\/acs.molpharmaceut.9b00177","article-title":"Induction of mitochondrial cell death and reversal of anticancer drug resistance via nanocarriers composed of a triphenylphosphonium derivative of tocopheryl polyethylene glycol succinate","volume":"16","author":"Singh","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2025.101581_bib18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/adhm.201300600","article-title":"Nanostructural systems developed with positive charge generation to drug delivery","volume":"3","author":"An","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101581_bib19","first-page":"95","article-title":"Wongkham, Aberrant expression of CD44 in bile duct cancer correlates with poor prognosis","volume":"13","author":"Kunlabut","year":"2012","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101581_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10585-011-9414-8","article-title":"Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells","volume":"28","author":"Pongcharoen","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101581_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/ijms19041081","article-title":"Effective delivery of arsenic trioxide to HPV-positive cervical cancer cells using optimised liposomes: a size and charge study","volume":"19","author":"Akhtar","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101581_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","article-title":"Recent advances in drug delivery systems for targeting brain tumors","volume":"30","author":"Zhao","year":"2023","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101581_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/03639045.2017.1301948","article-title":"Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity","volume":"43","author":"Li","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.mtbio.2025.101581_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114648","article-title":"Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy","volume":"241","author":"Chen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/D0NH00605J","article-title":"Targeted liposomal drug delivery: a nanoscience and biophysical perspective","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horizons"},{"issue":"18","key":"10.1016\/j.mtbio.2025.101581_bib26","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.M116.770149","article-title":"A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase","volume":"292","author":"Yamamoto","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1006\/abbi.1993.1443","article-title":"Purification and characterization of human serum hyaluronidase","volume":"305","author":"Afify","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"issue":"35","key":"10.1016\/j.mtbio.2025.101581_bib28","doi-asserted-by":"crossref","first-page":"22466","DOI":"10.1074\/jbc.273.35.22466","article-title":"HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity","volume":"273","author":"Lepperdinger","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.mtbio.2025.101581_bib29","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/adma.201201498","article-title":"Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery","volume":"24","author":"Mo","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101581_bib30","article-title":"VDAC1 selective molecules promote patients-derived cancer organoids death through mitochondrial-dependent metabolic interference","author":"Conti Nibali","year":"2023","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3858\/emm.2009.41.2.013","article-title":"Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells","volume":"41","author":"Yoo","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mtbio.2025.101581_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2018.02.005","article-title":"Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease","author":"Ishikawa","year":"2018","journal-title":"J. Contr. Release: Official Journal of the Controlled Release Society"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101581_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2016.07.071","article-title":"Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons","volume":"478","author":"Hu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101581_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1595","article-title":"Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells","volume":"15","author":"Begum","year":"2023","journal-title":"WIREs Mechanisms of Disease"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101581_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbabio.2017.03.002","article-title":"VDAC in cancer","volume":"1858","author":"Mazure","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.mtbio.2025.101581_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109805","article-title":"Mollugin induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in hepatoma cells","volume":"353","author":"Ke","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101581_bib37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1878-0261.12308","article-title":"SALL2 represses cyclins D1 and E1 expression and restrains G1\/S cell cycle transition and cancer-related phenotypes","volume":"12","author":"Hermosilla","year":"2018","journal-title":"Mol. Oncol."},{"issue":"24","key":"10.1016\/j.mtbio.2025.101581_bib38","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","article-title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.mtbio.2025.101581_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124023","article-title":"N-Trimethylated chitosan coating white adipose tissue vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol","volume":"236","author":"Xian","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101581_bib40","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jhep.2017.07.006","article-title":"Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice","volume":"67","author":"Zhang","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cbin.11952","article-title":"Celastrol acts as a new histone deacetylase inhibitor to inhibit colorectal cancer cell growth via regulating macrophage polarity","volume":"47","author":"Wang","year":"2023","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2018.03.224","article-title":"Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages","volume":"503","author":"Yang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101581_bib43","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor\u2010associated macrophages in liver cancer: from mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.mtbio.2025.101581_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715359","article-title":"Tripterygium hypoglaucum (L\u00e9vl.) hutch and its main bioactive components: recent advances in pharmacological activity, pharmacokinetics and potential toxicity","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101581_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc723","article-title":"Natural products in cancer chemotherapy: past, present and future","volume":"2","author":"Mann","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2025.101581_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101581_bib47","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.101581_bib48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1166\/jnn.2020.16955","article-title":"Transferrin modified dioscin loaded PEGylated liposomes: characterization andIn vitroAntitumor effect","volume":"20","author":"Wang","year":"2020","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.mtbio.2025.101581_bib49","first-page":"124","volume":"vol. 64","author":"Liu","year":"2016"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101581_bib50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/acs.molpharmaceut.9b00428","article-title":"Celastrol-loaded galactosylated liposomes effectively inhibit AKT\/c-Met-triggered rapid hepatocarcinogenesis in mice","volume":"17","author":"Chen","year":"2020","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101581_bib51","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/cells8091026","article-title":"Synergistic and pharmacotherapeutic effects of gemcitabine and cisplatin combined administration on biliary tract cancer cell lines","volume":"8","author":"Sakamoto","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2025.101581_bib52","first-page":"763","article-title":"Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary","volume":"53","author":"Noh","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101581_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","article-title":"Hydrodynamic transfection for generation of novel mouse models for liver cancer research","volume":"184","author":"Chen","year":"2014","journal-title":"Am. J. Pathol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:31:02Z","timestamp":1778905862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S2590006425001395"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101581","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of dual-targeted liposomes loaded with celastrol and their application in treating intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101581"}}